GPT Antibodies

Santa Cruz Biotechnology features a diverse variety of GPT Antibodies for advanced research in protein studies. GPT Antibodies are compatible with western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Glutamate pyruvate transaminase (GPT), also known as alanine aminotransferase (ALT), plays a crucial role in amino acid metabolism and the urea cycle, making it an important biomarker for liver function and health. Elevated levels of GPT can indicate liver damage or disease, underscoring its significance in clinical diagnostics and research. Understanding the function and regulation of GPT is essential for developing therapeutic strategies for liver-related conditions. GPT monoclonal antibodies enable researchers to investigate cellular pathways and molecular mechanisms involved in liver disorders. Studying GPT expression patterns helps identify potential therapeutic targets and biomarkers for liver diseases. GPT research contributes to understanding metabolic disorders and their impact on overall health. Santa Cruz Biotechnology monoclonal antibodies for GPT support researchers worldwide in advancing our understanding of liver biology and disease mechanisms.